ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair

September 19, 2014

Roswell Park Wins Competition for Organ Systems Coordinating Center

May 18, 1984

Alan Rabson Named Acting NCI Director

October 5, 2001

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985